Average Co-Inventor Count = 7.87
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biocure Limited (6 from 15 patents)
2. Focal, Inc. (4 from 40 patents)
3. University of Texas System (2 from 5,444 patents)
4. Genzyme Corporation (2 from 787 patents)
5. Other (1 from 832,680 patents)
6. Biocompatibles UK Limited (1 from 90 patents)
14 patents:
1. RE48302 - Embolic compositions
2. RE47873 - Embolic compositions
3. RE47121 - Embolic compositions
4. 8221735 - Embolic compositions
5. RE39713 - Polymerizable biodegradable polymers including carbonate or dioxanone linkages
6. 7070809 - Hydrogel biomedical articles
7. 7008635 - Hydrogels for orthopedic repair
8. 6676971 - Embolic compositions
9. 6652883 - Tissue bulking and coating compositions
10. 6387977 - Redox and photoinitiator systems for priming for improved adherence of gels to substrates
11. 6177095 - Polymerizable biodegradable polymers including carbonate or dioxanone linkages
12. 6121341 - Redox and photoinitiator systems for priming and improved adherence of
13. 6083524 - Polymerizable biodegradable polymers including carbonate or dioxanone
14. 5844016 - Redox and photoinitiator priming for improved adherence of gels to